European Respiratory Journal

The ERJ publishes clinical and experimental work relating to all aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine and thoracic surgery. In addition to original research material, the ERJ also publishes editorial commentaries, reviews, short research letters and correspondence to the editor. Articles are published continuously and collected into 12 monthly issues in two volumes per year.

February

ERJ February Podcast: precision medicine in chronic airway diseases Eur Respir J 2016; 47: E62
Chronic diseases like asthma and COPD: do they truly exist? Sterk Peter J. Eur Respir J 2016; 47: 359-361
Asthma phenotypes in childhood: conceptual thoughts on stability and transition Spycher Ben Daniel, Kuehni Claudia Elisabeth Eur Respir J 2016; 47: 362-365
Stressful sleep Jun Jonathan C., Polotsky Vsevolod Y. Eur Respir J 2016; 47: 366-368
Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis? Lankeit Mareike, Held Matthias Eur Respir J 2016; 47: 369-373
Optimising treatment for post-operative lung cancer recurrence Subotic Dragan, Van Schil Paul, Grigoriu Bogdan Eur Respir J 2016; 47: 374-378
Ageing lungs and very elderly COPD: anytime and anywhere Soriano Joan B., Suissa Samy Eur Respir J 2016; 47: 379-381
The bronchiectasis severity index and FACED score for bronchiectasis Guan Wei-jie, Chen Rong-chang, Zhong Nan-shan Eur Respir J 2016; 47: 382-384
Treating allergic bronchopulmonary aspergillosis: the way forward Moss Richard B. Eur Respir J 2016; 47: 385-387
Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances? Toshner Mark Eur Respir J 2016; 47: 388-389
Sex differences in pulmonary hypertension: are we cleaning up the mess? Lahm Tim Eur Respir J 2016; 47: 390-393
Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence Pontali Emanuele, Sotgiu Giovanni, D'Ambrosio Lia, Centis Rosella, Migliori Giovanni Battista Eur Respir J 2016; 47: 394-402
European IPF Patient Charter: an SOS to the world Crestani Bruno Eur Respir J 2016; 47: 403-405
Prenatal stress and childhood asthma risk: taking a broader view Lee Alison, Wright Rosalind J. Eur Respir J 2016; 47: 406-409
Treatable traits: toward precision medicine of chronic airway diseases Agusti Alvar, Bel Elisabeth, Thomas Mike, Vogelmeier Claus, Brusselle Guy, Holgate Stephen, Humbert Marc, Jones Paul, Gibson Peter G., Vestbo Jørgen, Beasley Richard, Pavord Ian D. Eur Respir J 2016; 47: 410-419
Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis Elborn J. Stuart, Bell Scott C., Madge Susan L., Burgel Pierre-Regis, Castellani Carlo, Conway Steven, De Rijcke Karleen, Dembski Birgit, Drevinek Pavel, Heijerman Harry G.M., Innes J. Alistair, Lindblad Anders, Marshall Bruce, Olesen Hanne V., Reimann Andreas L., Solé Ampara, Viviani Laura, Wagner Thomas O.F., Welte Tobias, Blasi Francesco Eur Respir J 2016; 47: 420-428
Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement Puente-Maestu Luis, Palange Paolo, Casaburi Richard, Laveneziana Pierantonio, Maltais François, Neder J. Alberto, O'Donnell Denis E., Onorati Paolo, Porszasz Janos, Rabinovich Roberto, Rossiter Harry B., Singh Sally, Troosters Thierry, Ward Susan Eur Respir J 2016; 47: 429-460
Incidence of airflow limitation in subjects 65–100?years of age Luoto Johannes A., Elmståhl Sölve, Wollmer Per, Pihlsgård Mats Eur Respir J 2016; 47: 461-472
COPD and risk of venous thromboembolism and mortality in a general population Børvik Trond, Brækkan Sigrid K., Enga Kristin, Schirmer Henrik, Brodin Ellen E., Melbye Hasse, Hansen John-Bjarne Eur Respir J 2016; 47: 473-481
Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study Ellis Huw C., Cowman Steven, Fernandes Michele, Wilson Robert, Loebinger Michael R. Eur Respir J 2016; 47: 482-489
A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma Agarwal Ritesh, Aggarwal Ashutosh N., Dhooria Sahajal, Singh Sehgal Inderpaul, Garg Mandeep, Saikia Biman, Behera Digambar, Chakrabarti Arunaloke Eur Respir J 2016; 47: 490-498
Change in the manifestations of asthma and asthma-related traits in childhood: a latent transition analysis Garden Frances L., Simpson Judy M., Mellis Craig M., Marks Guy B. Eur Respir J 2016; 47: 499-509
Childhood wheezing phenotypes influence asthma, lung function and exhaled nitric oxide fraction in adolescence Duijts Liesbeth, Granell Raquel, Sterne Jonathan A.C., Henderson A. John Eur Respir J 2016; 47: 510-519
Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37 Schögler Aline, Muster Ricardo J., Kieninger Elisabeth, Casaulta Carmen, Tapparel Caroline, Jung Andreas, Moeller Alexander, Geiser Thomas, Regamey Nicolas, Alves Marco P. Eur Respir J 2016; 47: 520-530
Sleep apnoea and the hypothalamic–pituitary–adrenal axis in men and women: effects of continuous positive airway pressure Kritikou Ilia, Basta Maria, Vgontzas Alexandros N., Pejovic Slobodanka, Fernandez-Mendoza Julio, Liao Duanping, Bixler Edward O., Gaines Jordan, Chrousos George P. Eur Respir J 2016; 47: 531-540
Genetic counselling in a national referral centre for pulmonary hypertension Girerd Barbara, Montani David, Jaïs Xavier, Eyries Mélanie, Yaici Azzedine, Sztrymf Benjamin, Savale Laurent, Parent Florence, Coulet Florence, Godinas Laurent, Lau Edmund M., Tamura Yuichi, Sitbon Olivier, Soubrier Florent, Simonneau Gérald, Humbert Marc Eur Respir J 2016; 47: 541-552
Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function Ventetuolo Corey E., Mitra Nandita, Wan Fei, Manichaikul Ani, Barr R. Graham, Johnson Craig, Bluemke David A., Lima Joao A.C., Tandri Hari, Ouyang Pamela, Kawut Steven M. Eur Respir J 2016; 47: 553-563
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis Pym Alexander S., Diacon Andreas H., Tang Shen-Jie, Conradie Francesca, Danilovits Manfred, Chuchottaworn Charoen, Vasilyeva Irina, Andries Koen, Bakare Nyasha, De Marez Tine, Haxaire-Theeuwes Myriam, Lounis Nacer, Meyvisch Paul, Van Baelen Ben, van Heeswijk Rolf P.G., Dannemann Brian Eur Respir J 2016; 47: 564-574
Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals Diel Roland, Nienhaus Albert, Hillemann Doris, Richter Elvira Eur Respir J 2016; 47: 575-587
Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease Solomon Joshua J., Chung Jonathan H., Cosgrove Gregory P., Demoruelle M. Kristen, Fernandez-Perez Evans R., Fischer Aryeh, Frankel Stephen K., Hobbs Stephen B., Huie Tristan J., Ketzer Jill, Mannina Amar, Olson Amy L., Russell Gloria, Tsuchiya Yutaka, Yunt Zulma X., Zelarney Pearlanne T., Brown Kevin K., Swigris Jeffrey J. Eur Respir J 2016; 47: 588-596
European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers Bonella Francesco, Wijsenbeek Marlies, Molina-Molina Maria, Duck Annette, Mele Rosalba, Geissler Klaus, Wuyts Wim Eur Respir J 2016; 47: 597-606
Sequential multimodality bronchoscopic investigation of peripheral pulmonary lesions Steinfort Daniel P., Bonney Asha, See Katharine, Irving Louis B. Eur Respir J 2016; 47: 607-614
Clinical features of large cell neuroendocrine carcinoma: a population-based overview Derks Jules L., Hendriks Lizza E., Buikhuisen Wieneke A., Groen Harry J.M., Thunnissen Erik, van Suylen Robert-Jan, Houben Ruud, Damhuis Ronald A., Speel Ernst J.M., Dingemans Anne-Marie C. Eur Respir J 2016; 47: 615-624
A review of national guidelines for management of COPD in Europe Miravitlles Marc, Vogelmeier Claus, Roche Nicolas, Halpin David, Cardoso João, Chuchalin Alexander G., Kankaanranta Hannu, Sandström Thomas, ?liwi?ski Pawe?, Zatloukal Jaromir, Blasi Francesco Eur Respir J 2016; 47: 625-637
Inflammatory bowel diseases, chronic liver diseases and the lung Rodriguez-Roisin Roberto, Bartolome Sonja D., Huchon Gérard, Krowka Michael J. Eur Respir J 2016; 47: 638-650
Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD Magnussen Helgo, Tetzlaff Kay, Bateman Eric D., Watz Henrik, Kirsten Anne M., Wouters Emiel F.M., Disse Bernd, Finnigan Helen, Rodriguez-Roisin Roberto, Calverley Peter M.A. Eur Respir J 2016; 47: 651-654
Bacteraemia in outpatients with community-acquired pneumonia Cillóniz Catia, Gabarrús Albert, Almirall Jordi, Amaro Rosanel, Rinaudo Mariano, Travierso Chiara, Niederman Michael, Torres Antoni Eur Respir J 2016; 47: 654-657
Improving end-of-life communication between primary and secondary care within respiratory medicine Boland Alison C., Hodgekiss Claire, Hicks Fiona, Edwards Annette, Clifton Ian J. Eur Respir J 2016; 47: 658-660
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens Losi Monica, Knights Ashley J., Mariani Francesca, Altieri Alfonso M., Paone Gregorino, Loxton Andre G., Chegou Novel N., Kenneth John, Alma Mario G., Colizzi Vittorio, Walzl Gerhard, Saltini Cesare, Boyle Jeff, Amicosante Massimo Eur Respir J 2016; 47: 660-664
Tuberculosis elimination, patients' lives and rational use of new drugs: revisited Tiberi Simon, D'Ambrosio Lia, De Lorenzo Saverio, Viggiani Pietro, Centis Rosella, Migliori Giovanni Battista Eur Respir J 2016; 47: 664-667
Tuberculosis in Germany: a declining trend coming to an end? Fiebig Lena, Hauer Barbara, Brodhun Bonita, Altmann Doris, Haas Walter Eur Respir J 2016; 47: 667-670
Recruitment challenges for clinical trials with novel regimens for drug-resistant tuberculosis Siwendu Sweetness, Mitchell Melissa, Diacon Andreas H., von Groote-Bidlingmaier Florian Eur Respir J 2016; 47: 670-672
Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis Huitema Marloes P., Spee Marcela, Vorselaars Veronique M.M., Boerman Sanne, Snijder Repke J., van Es Hendrik W., Reesink Herre J., Grutters Jan C., Post Marco C. Eur Respir J 2016; 47: 673-676
Pulmonary hypertension associated with ponatinib therapy Quilot Fleur-Marie, Georges Marjolaine, Favrolt Nicolas, Beltramo Guillaume, Foignot Clément, Grandvuillemin Aurélie, Montani David, Bonniaud Philippe, Camus Philippe Eur Respir J 2016; 47: 676-679
End TB with precision treatment! van der Burgt Evelien P.M., Sturkenboom Marieke G.G., Bolhuis Mathieu S., Akkerman Onno W., Kosterink Jos G.W., de Lange Wiel C.M., Cobelens Frank G.J., van der Werf Tjip S., Alffenaar Jan-Willem C. Eur Respir J 2016; 47: 680-682
?-blockers in pulmonary arterial hypertension: generation might matter Malenfant Simon, Perros Frédéric Eur Respir J 2016; 47: 682-684
Cameroon's MDR-TB treatment programme jeopardised by cross-border migration Noeske Jürgen, Foe Jean-Louis Abena, Kuaban Christopher Eur Respir J 2016; 47: 684-686
Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration Matteelli Alberto, Lönnroth Knut, Mosca Davide, Getahun Haileyesus, Centis Rosella, D'Ambrosio Lia, Jaramillo Ernesto, Migliori Giovanni Battista, Raviglione Mario C. Eur Respir J 2016; 47: 686-688
Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy? Merad Mansouria, Savale Laurent, Antoun Sami, Vincent François Eur Respir J 2016; 47: 688-690
Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy Price Laura C., Wort S. John Eur Respir J 2016; 47: 690-691
“Cladribine improves lung cysts and pulmonary function in a child with histiocytosis.” Ralph Epaud, Hubert Ducou Le Pointe, Sylvie Fasola, Sandra Ploussard, Celine Delestrain, Chiara Sileo and Jean Donadieu. Eur Respir J 2015; 45: 831–833. Eur Respir J 2016; 47: 692